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NK cells are phenotypically and functionally diverse lymphocytes due to variegated
expression of a large array of receptors. NK-cell activity is tightly regulated through
integration of receptor-derived inhibitory and activating signals. Thus, the receptor profile
of each NK cell ultimately determines its ability to sense aberrant cells and subsequently
mediate anti-viral or anti-tumor responses. However, an in-depth understanding of how
different receptor repertoires enable distinct immune functions of NK cells is lacking.
Therefore, we investigated the phenotypic diversity of primary human NK cells by
performing extensive phenotypic characterization of 338 surface molecules using flow
cytometry (n = 18). Our results showed that NK cells express at least 146 receptors on
their surface. Of those, 136 (>90%) exhibited considerable inter-donor variability.
Moreover, comparative analysis of CD56bright and CD56dim NK cells identified 70
molecules with differential expression between the two major NK-cell subsets and
allowed discrimination of these subsets via unsupervised hierarchical clustering. These
receptors were associated with a broad range of NK-cell functions and multiple molecules
were not previously associated with predominant expression on either subset (e.g. CD82
and CD147). Altogether, our study contributes to an improved understanding of the
phenotypic diversity of NK cells and its potential functional implications on a cellular and
population level. While the identified distinct signatures in the receptor repertoires provide
a molecular basis for the differential immune functions exerted by CD56bright and
CD56dim NK cells, the observed inter-individual differences in the receptor repertoire of
NK cells may contribute to a diverging ability to control certain diseases.
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Natural killer (NK) cells are innate lymphocytes that mediate anti-
viral (1) and anti-tumor (2) responses. NK-cell effector functions
include direct lysis of target cells as well as production of pro-
inflammatory cytokines such as IFNg and TNFa (3). NK cells utilize
a large array of germline-encoded surface receptors to interact with
their environment, sense aberrant cells and subsequently mount
potent effector responses. Among others, NK cells express receptors
recognizing MHC class I molecules, stress ligands and cytokines as
well as adhesion molecules and costimulatory receptors (4, 5). NK-
cell activation is dependent on the integration of activating and
inhibitory signals from multiple receptors. NK cells exert effector
functions when signaling from their activating and costimulatory
receptors outweighs signaling from their inhibitory receptors (4).
Therefore, the receptor repertoire of a given NK cell ultimately
determines its ability to sense and counteract environmental threats.
In humans, two major NK-cell subsets can be distinguished
and are characterized by the differential expression of the
adhesion molecule CD56 and the low-affinity Fc receptor
CD16 (FcgRIIIa) (6, 7). They are commonly referred to as
CD56bright and CD56dim NK cells. CD56dim NK cells
predominate in peripheral blood whereas CD56bright NK cells
constitute the majority of NK cells in secondary lymphoid tissues
(e.g. lymph nodes) and several organ tissues (e.g. liver, uterus,
and kidneys) (8). According to current understanding of NK-cell
development, CD56bright and CD56dim NK cells both represent
mature NK-cell subsets with distinct functional and phenotypic
characteristics. Yet, CD56dim NK cells are more terminally
differentiated and can arise from CD56bright NK cells (9–11).
In the classical dichotomy, CD56dim NK cells are the cytotoxic
“effector” NK cells while CD56bright NK cells are more
“immunoregulatory,” i.e. produce vast amounts of cytokines
and have superior proliferative capacities (3). CD56dim NK
cells have higher expression of CD16, perforin and granzymes
which enable them to mediate potent cytotoxicity and ADCC (8).
However, this classical assignment of roles has been challenged
by data showing enhanced cytotoxic responses from CD56bright
NK cells upon stimulation with cytokines as well as vast
production of cytokines by CD56dim NK cells following target
cell recognition via surface-bound ligands or antibodies that
trigger CD16 (8, 12). Still, an in-depth understanding of the
distinct functional roles of CD56bright and CD56dim NK cells
and how those are enabled by differences in their receptor
repertoires is lacking.
Human individuals bear approximately 6,000–30,000
different NK-cell phenotypes, and >100,000 different NK-cell
phenotypes are present on a larger population level (13). The
discovery of this high degree of cell-to-cell variability in a given
NK-cell population has led to a growing appreciation for the
remarkable phenotypic and functional heterogeneity of NK cells.
Coinciding, multiple specialized, tissue-resident NK-cell subsets
have been discovered in various tissues that fulfil distinct tissue-
specific functions and are characterized by unique phenotypes (8,
14). Nevertheless, the molecular determinants of NK-cell-
mediated recognition of aberrant cells remain incompletelyFrontiers in Immunology | www.frontiersin.org 2understood. Given the close link between surface expression
and immune functions in NK cells, further in-depth phenotypic
characterization of NK cells is a prerequisite in gaining a better
insight of how NK cells mediate their effector responses. These
efforts may subsequently assist in identifying highly functional
NK-cell subsets recognizing virus-infected or malignant cells.
Thus, we aimed to comprehensively characterize the phenotypic
diversity of human NK cells and the repertoire of surface
molecules that NK cells utilize to interact with their
environment. Using a flow cytometry-based approach, we
assessed the surface expression of 338 molecules on human
peripheral blood NK cells. This allowed detailed phenotypic
characterization of primary NK cells, the assessment of inter-
individual variability in receptor surface expression and
comparative analyses between CD56bright and CD56dim
NK cells.METHODS
Peripheral Blood Sample Acquisition and
Processing
Citrate-treated peripheral blood samples were obtained from
healthy blood donors recruited at the Institute for Transfusion
Medicine, University Medical Center Hamburg-Eppendorf,
Hamburg, Germany. Peripheral blood mononuclear cells
(PBMCs) were isolated by density-gradient centrifugation,
washed, and subsequently resuspended in complete medium
(RPMI 1640 Medium, Thermo Fisher Scientific, Waltham,
MA, USA) supplemented with 10% (v/v) fetal bovine serum
(FBS, Biochrom GmbH, Berlin, Germany), 100 U/ml penicillin
and 100 µg/ml streptomycin (Sigma Aldrich, St. Louis,
MO, USA).
Enrichment of NK Cells
Primary NK cells were enriched from PBMCs using an
immunomagnetic negative selection strategy (EasySep Human
NK cell Isolation Kit, Stemcell Technologies, VA, Canada)
according to the manufacturer’s protocol. Enriched NK cells
were suspended in complete medium at a density of 5 × 106 cells/
ml and cultured overnight in the presence of low-dose
recombinant human IL-15 (5 ng/ml) and recombinant human
IL-2 (50 U/ml) at 37 °C, 5% (v/v) CO2.
Antibodies and Flow Cytometry
Multi-parameter flow cytometry was used for phenotypic and
functional characterization of NK cells. Cells were acquired using
a BD LSRFortessa flow cytometer (BD Biosciences, Franklin
Lakes, NJ, USA). Data was further analyzed using FlowJo
10.6.1 software (FlowJo, Ashland, OR, USA). A comprehensive
list of all antibodies and reagents is provided in Supplementary
Table 1. The corresponding gating strategy is displayed in
Supplementary Figure 1. Gating on educated and uneducated
NK cells was based on HLA class I genotyping (Supplementary
Table 2).December 2020 | Volume 11 | Article 568927
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Phenotypic Analysis
Expression of up to 338 individual surface molecules was
assessed using flow cytometry. Enriched primary peripheral
blood NK cells were washed and resuspended in DPBS (Sigma
Aldrich, St. Louis, MO, USA) supplemented with 1 mM EDTA
and 2% (v/v) FBS. Cells from up to four different donors were
multiplexed using distinct combinations of a-hCD45 conjugated
to BV605 or AF700 (donor 1: no AB, donor 2: AF700, donor 3:
BV605, donor 4: AF700 + BV605) to allow for re-identification of
NK cells from the respective donors. Additional surface staining
for viability, expression of CD3, CD14, CD16, CD19, and CD56
as well as for the NK-cell receptors KIR2DL1, KIR2DL2/L3,
KIR3DL1, NKG2A, NKG2C, and CD57 was performed. NK cells
from different donors were washed with DPBS and then
combined. Subsequently, cells were stained with pre-titrated
APC-conjugated antibodies for a total of 384 surface antigens
and controls (MACS marker screen, human, Miltenyi Biotec,
Bergisch Gladbach, Germany) following the manufacturer’s
instructions. Surface expression was assessed as relative
frequency of NK cells positive for each marker as well as
median fluorescence intensity (MFI) of each marker within the
respective subset. Placement of gates was based on FMO controls
(Supplementary Figure 1).Statistical Analysis
Data of cell populations (% of positive cells), for which the parent
population (denominator of the %) was <100 cells were set as
missing, and analyses performed on available (non-missing) data.
Data presentation of individual antigens and sub-populations in
figures may therefore deviate from the reported overall number of
individuals. Hierarchical clustering and principal component
analyses were used to describe the relationships between cell
populations. For the analyses of bulk NK cells, only cell
populations with an inter-donor range of ≥5 percentage point
(p.p.) were included in these analyses, the other cell populations
being considered of little interest for the research question due to
their low inter-donor variability in surface expression. Chi-square
test was used for comparison of overall expression on CD56bright
and CD56dim NK cells. Paired comparisons of CD56bright and
CD56dim NK-cell subsets were done with the Wilcoxon signed
rank test and adjusted for multiplicity using the Benjamini and
Hochberg false discovery rate (FDR) (15). FDR-adjusted p-values
<0.05 were considered statistically significant, and a median
difference of >5% between subsets was considered of biological
interest. Categorization of surfacemolecules into functional groups
was based on manual annotation using GO identifiers (16, 17).
Spearman’s r was used for correlation of median MFI and median
% of positive NK cells. Wilcoxon signed rank test without
multiplicity adjustment was used for paired comparison of the
MFI of HLA-E between CD56bright and CD56dim NK cells.
Analyses were performed using R software (The R
foundation, Vienna, Austria), version 3.6.1, and GraphPad
Prism (GraphPad Software, La Jolla, CA, USA), version 8.2.1.Frontiers in Immunology | www.frontiersin.org 3RESULTS
Aim of the Study and Overview
of Workflow
The aim of the study was to comprehensively characterize the
phenotypic diversity of human NK cells in order to gain new
insights into the receptor repertoires NK cells utilize to interact with
their environment and to mediate their effector functions. As
depicted in Figure 1, enriched human primary peripheral blood
NK cells from multiple donors were multiplexed using a-hCD45
and then stained for 384 individual surface antigens and controls in
a high-throughput manner using flow cytometry. Controls and
surface antigens used for identification of NK cells and their subsets
were excluded from further analysis (Supplementary Table 1).
Therefore, this approach allowed comparison of the surface
expression of 338 molecules on NK cells. We observed multiple
different receptor-specific expression patterns among NK cells
(Figure 1C). This included the complete lack of receptor
expression (e.g. CD1c), binary expression patterns (e.g. CD131) as
well as expression with differential surface densities on all NK cells
(low: e.g. CD95, high e.g. CD46). Downstream analyses focused on
phenotypic characterization of bulk NK cells and inter-individual
variability in expression (Figure 2) as well as comparative analysis
between the two major CD56bright and CD56dim NK-cell subsets
(Figures 3–6). Median fluorescence intensity (MFI) and relative
frequency (% positive NK cells) for each surface antigen were
determined as parameters of expression. Spearman’s r confirmed
a significant correlation between both parameters (Supplementary
Figure 2, rs = 0.86, p < 0.0001). Main statistical analyses were
conducted using relative frequency (% positive NK cells), therefore
the main manuscript displays figures showing relative frequency of
expression data. Similar figures showing MFI are presented in the
data supplement as indicated.NK Cells Express at Least 146
Different Surface Molecules
First, the overall expression of the 338 tested surface antigens on
bulk NK cells was assessed (Figure 2A). Data for all 338 surface
markers (including MFI) on bulk NK cells as well as CD56bright
and CD56dimNK-cell subsets is compiled in Supplementary Table
3. Using a threshold of 5% median percentage of positive NK cells
for each surface antigen, we identified 93 molecules expressed on
NK cells. Out of those, 25 antigens had a median percentage of
>95% positive NK cells. Another 25 molecules were expressed in
median on the majority of NK cells and 43 antigens to a lesser
degree (Figure 2B).
In addition to identifying surface molecules with expression
on NK cells using a strict cutoff, we selected all 136 surface
molecules with a minimum inter-donor range of ≥5 p.p. for
subsequent principal component analysis. The majority of these
markers (83 out of 136) were expressed above the 5% median
percentage cut off (Figure 2C). However, 53 markers with a
minimum inter-donor range of ≥5 p.p. had a median expression
of less than 5%. This selection criterion of minimum inter-December 2020 | Volume 11 | Article 568927
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surface molecules that may contribute to differences in NK-cell
phenotypes and functionality between individuals. The
relationship between these 136 surface molecules and their
respective impact on overall phenotypic variability are shown
in Figure 2D. While markers with higher median expression
tend to be located in the upper part of the PCA plot, surfaceFrontiers in Immunology | www.frontiersin.org 4antigens with low median expression are preferentially plotted in
the lower part of the PCA. In the particular, some of the latter
form a clear cluster with increased impact on the overall
phenotypic variability. Despite excluding surface antigens from
further analysis that were uniformly expressed on all NK cells
using this threshold of minimum inter-donor range, we
identified an increased number of molecules compared toA
B
DC
FIGURE 1 | Overview of workflow and conducted experiments. (A) Primary human NK cells from peripheral blood of healthy donors were enriched by density
gradient centrifugation and subsequent immunomagnetic negative selection. Enriched cells were cultured overnight in low-dose IL-2 (50 U/ml) and IL-15 (5 ng/ml).
(B) For flow cytometric identification and purity assessment of NK cells, cells were stained for the expression of the lineage markers CD3, CD14, CD19, CD16, and
CD56. For further discrimination of educated and uneducated sub-populations, NK cells were additionally labeled with antibodies against NKG2A, KIR3DL1,
KIR2DL1, and KIR2DL2/L3. NK cells from up to four individual donors were subsequently multiplexed for further NK-cell phenotyping using a-hCD45. Multiplexed
NK cells were stained with 384 antibodies and controls against surface antigens (n = 18). (C) Controls and surface antigens used for identification of NK cells and
their subsets were excluded from further analysis. Therefore, expression of 338 surface antigens was assessed on NK cells. Exemplary dot plots show differential
patterns of expression. (D) Downstream analyses focused on phenotypic characterization of NK cells and assessment of inter-individual variability in surface
expression (Figure 2) as well as phenotypic differences between CD56bright and CD56dim NK cells (Figures 3–6).December 2020 | Volume 11 | Article 568927
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additional receptors were TLT-2, LAG-3 (CD223), CD70, CD27
(TNFR), and CD39 which have been implicated in various NK-
cell functions (e.g. target cell recognition).
Finally, we investigated receptors exhibiting very high variability
in surface expression between individuals. Forty-seven surfaceFrontiers in Immunology | www.frontiersin.org 5molecules demonstrated an inter-donor range of >50 p.p. and the
largest ranges of expression were observed for surface molecules
CD58 (LFA-3) (range 95 p.p.), CD205 (range 94 p.p.), CD161
(range 93 p.p.), CXCR2 (range 86 p.p.), and CD2 (range 85 p.p.).
Combining our two selection criteria (median expression
>5% or inter-donor range ≥5 p.p.), we detected a total of 146A
B D
C
FIGURE 2 | Phenotypic characterization of bulk NK cells and assessment of inter-individual variability. Surface expression of 338 different surface molecules on NK
cells was assessed using flow cytometry (n = 18). (A) Distribution of expression of surface antigens on NK cells displayed as % positive NK cells. Bar graphs show
IQR of expression of the respective surface molecule and black bars indicate the median. Surface molecules were ranked descending by median expression.
(B) Summary table shows numeric results for overall surface expression. A total of 93 surface molecules exhibited a median expression of >5% of NK cells. (C) Venn
diagram displaying the number of markers identified on NK cells with a median expression of >5% and/or a minimum inter-donor range of ≥5 p.p. (D) Principal
component analysis was performed on all 136 surface antigens with a minimum inter-donor range of ≥5 p.p. (i.e. on all molecules with inter-individual variability in
surface expression). Circle size indicates quality of representation (cos2) of each surface molecule.December 2020 | Volume 11 | Article 568927




FIGURE 3 | Intra-individual differences in surface expression between CD56bright and CD56dim NK-cell subsets. Expression of 338 different surface antigens on
CD56bright and CD56dim NK cells was assessed using flow cytometry (n = 18). (A) Overall distribution of surface expression on CD56bright and CD56dim NK-cell
subsets displayed as % positive NK cells. Bar graphs show IQR of expression of the respective molecule and white/black bars indicate the median. Surface antigens
were ranked descending by median expression for each subset separately, thus their orders are not identical. (B) Summary tables show numeric results for overall
surface expression on CD56bright and CD56dim NK cells. Eighty-four and 92 surface molecules were expressed on CD56bright and CD56dim NK cells, respectively
(>5% median expression). A total of 104 surface antigens were consistently expressed on at least one of these NK-cell subsets. (C) Expression of all 338 surface
antigens was compared between CD56bright and CD56dim NK cells. Wilcoxon signed rank tests were performed between subpopulations with an FDR adjustment
for test multiplicity. Data was analyzed regarding median differences in expression >5 p.p. and statistical significance (FDR-adjusted p < 0.05). Representative bar
graphs show exemplary data for all possible combinations of the two criteria. (D) Summary table shows numeric results. All 70 surface molecules with statistically
significant differences >5 p.p. in expression between CD56bright and CD56dim NK cells were grouped according to their function.Frontiers in Immunology | www.frontiersin.org December 2020 | Volume 11 | Article 5689276
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those did not meet our inter-donor range criterion which
emphasizes how common inter-individual variability in NK-
cell receptor expression is.
CD56bright and CD56dim NK Cells
Express Similar Numbers of Receptors
Next, we assessed the overall expression of surface antigens on the
two major NK-cell subsets CD56bright and CD56dim NK cells.
Using a threshold of 5% median percentage of positive NK cells
for each of the surface antigens, we observed expression of 84 and
92 molecules on CD56bright and CD56dim NK cells, respectively.
CD56bright and CD56dim NK cells displayed similar patterns of
overall distribution (Figure 3A). Twenty-four and 29 antigens were
in median expressed on >95% of CD56bright or CD56dim NKFrontiers in Immunology | www.frontiersin.org 7cells, respectively. Another 25 and 22 molecules were expressed on
the majority of NK cells from both subsets. Additionally, 35 and 41
antigens were expressed on CD56bright and CD56dim NK cells to
a lesser degree (Figure 3B). Overall, these differences were not
statistically significant (c2 = 1.265, p = 0.73). These data indicate
that both CD56bright and CD56dim NK cells express very similar
numbers of surface receptors. A total of 104 surface molecules was
expressed on at least one of the major NK-cell subsets.
CD56bright and CD56dim NK Cells
Are Differentially Equipped With
Surface Receptors
Subsequently, we aimed to characterize the phenotypic differences
between the two major NK-cell subsets by comparing the
expression of all 338 surface antigens on CD56bright andA
B
FIGURE 4 | Intra-individual differences in surface expression of adhesion molecules and NK-cell receptors between CD56bright and CD56dim NK-cell subsets. NK
cells were assessed for surface expression of 338 different surface antigens using flow cytometry (n = 18). Wilcoxon signed rank tests were performed between
subpopulations with a Benjamini and Hochberg FDR adjustment for test multiplicity. Seventy molecules displayed a median difference >5 percentage points between
CD56bright and CD56dim NK cells and were statistically significant (FDR-adjusted p < 0.05). Those 70 surface molecules were subsequently grouped according to
their function. Bars indicate median expression (% positive NK cells) of all members of the groups titled adhesion molecules (A) and NK-cell receptors (B).December 2020 | Volume 11 | Article 568927
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significant differences in expression between the two NK-cell
subsets which were defined as median difference in surface
expression >5 p.p. with an FDR-adjusted p < 0.05 (Figure 3C).
Median differences within the positive range indicate higherFrontiers in Immunology | www.frontiersin.org 8expression on CD56dim NK cells whereas negative values
represent a higher expression on CD56bright NK cells. Only 34
out of the 104 receptors expressed on at least one of the subsets
were not differentially expressed between CD56bright and




FIGURE 5 | Intra-individual differences in surface expression of cytokine and chemokine receptors, activation and differentiation, survival/apoptosis, and
miscellaneous molecules between CD56bright and CD56dim NK-cell subsets. NK cells were assessed for surface expression of 338 different surface antigens using
flow cytometry (n = 18). Wilcoxon signed rank tests were performed between subpopulations with a Benjamini and Hochberg FDR adjustment for test multiplicity.
Seventy molecules displayed a median difference >5 percentage points between CD56bright and CD56dim NK cells and were statistically significant (FDR-adjusted
p < 0.05). Those 70 surface molecules were subsequently grouped according to their function. Bars indicate median expression (% positive NK cells) of all members
of the groups titled cytokine and chemokine receptors (A), activation and differentiation (B), survival/apoptosis (C), and miscellaneous (D).December 2020 | Volume 11 | Article 568927
Schwane et al. Receptor Repertoires of Human NK Cellsstimulatory 2B4 and adhesion molecules CD18 and CD11a (the
two subunits of LFA-1). The majority of receptors—70 out of
104—exhibited differential surface expression between the
two subsets.Frontiers in Immunology | www.frontiersin.org 9All 70 markers with differential expression were categorized
into six groups according to their function—adhesion molecules,
NK-cell receptors, cytokine and chemokine receptors, survival/
apoptosis, activation and differentiation, as well as miscellaneousFIGURE 6 | Receptor expression-based unsupervised hierarchical clustering of CD56bright and CD56dim NK cells. NK cells were assessed for surface expression
of 338 different surface antigens using flow cytometry (n = 18). Wilcoxon signed rank tests were performed between subpopulations with a Benjamini and Hochberg
FDR adjustment for test multiplicity. Seventy molecules displayed a median difference >5 p.p. between CD56bright and CD56dim NK cells and were statistically
significant (FDR-adjusted p < 0.05). Heatmap displaying frequency of surface antigen-expressing NK cells based on these 70 molecules in CD56bright (left) and
CD56dim NK cells (right) for each donor. Field color indicates median surface expression (in %) on the respective NK-cell subset. Black fields represent missing or
excluded data (i.e. due to insufficient cell population size <100 cells). Unsupervised hierarchical clustering confirmed the major phenotypic differences as data clearly
clustered into CD56bright and CD56dim NK cells based on expression of surface molecules.December 2020 | Volume 11 | Article 568927
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the two major NK-cell subsets associate with a broad range of NK-
cell functions [Figures 4, 5, Supplementary Figure 4 (MFI)].
Several of the 70 surface molecules with differential expression
are known to be predominantly expressed by either CD56bright
[e.g. CD253 (TRAIL) (median difference −72 p.p., p < 0.0001),
CD55 (DAF) (−58 p.p., p < 0.0001), CD62L (−55 p.p., p < 0.0001),
NKG2A (−53 p.p., p < 0.0001)] or CD56dim NK cells [e.g.
CX3CR1 (91 p.p., p < 0.0001), CD57 (51 p.p., p < 0.0001),
CXCR1 (20 p.p., p < 0.0001)]. Moreover, we identified multiple
surface molecules that were not previously associated with
predominant expression on either CD56bright [e.g. CD82
(median difference −41 p.p., p < 0.0001)] or CD56dim NK cells
[e.g. CD298 (72 p.p., p < 0.0001), CD58 (LFA-3) (56 p.p., p <
0.0001), CD147 (35 p.p., p < 0.0001), HLA-E (55 p.p., p < 0.0001)].
Given the observed differences in receptor expression, we
tested whether CD56bright and CD56dim NK cells can be clearly
classified based on expression of these surface molecules.
Unsupervised hierarchical clustering confirmed the major
phenotypic differences between the cell subsets [Figure 6 and
Supplementary Figure 5 (MFI)]. Our data clustered into
CD56bright and CD56dim NK cells. A similar analysis
comparing uneducated and educated NK cells did not show
clustering based on expression of surface molecules
(Supplementary Figure 6).
Overall, our high-throughput phenotypic analysis revealed the
major phenotypic differences between CD56bright and CD56dim
NK cells among receptors with a broad range of functions that
were confirmed by unsupervised hierarchical clustering.DISCUSSION
Our comprehensive phenotypic characterization of NK cells
revealed relevant expression of 146 surface molecules on bulk
NK cells and considerable variability in expression for 136
molecules between individual donors. Of those, 53 showed a
donor-specific expression and were only detected on NK cells in
a subset of individuals. Among these receptors were CD27
(TNFR) and its ligand CD70, CD39, LAG-3, and TLT-2.
Expression of the receptor CD27 on subpopulations of NK
cells and its influence on target cell recognition were already
reported in the 1990s (18). More recently, reverse signaling via its
ligand CD70 was shown to also enhance NK-cell effector
functions and contribute to tumor immunosurveillance (19).
CD39 is an ectonucleotidase that contributes to high levels of
adenosine in the tumor microenvironment where adenosine
functions as an immunosuppressive metabolite and regulates
tumor immunosurveillance. Expression of CD39 was reported
for tumor infiltrating lymphocytes and, to a lesser degree, resting
NK cells. Currently, multiple substances targeting CD39—i.e.
monoclonal antibodies and enzyme inhibitors—are investigated
as potential therapeutic options for metastasized solid tumors as
CD39 enzyme activity seems especially relevant for NK-cell-
mediated control of metastases (20, 21). Those examples clearly
show how inter-individual differences in NK-cell phenotypesFrontiers in Immunology | www.frontiersin.org 10may underlie differential abilities to control certain diseases.
However, the function and biological significance of some
molecules with inter-individual differences in expression, such
as LAG-3 and TLT-2, remain rather elusive. LAG-3 is an
established surface marker for NK-cell exhaustion and
currently under investigation as a target for checkpoint
inhibition in tumor immunotherapy. As most data on NK-cell
exhaustion was generated in the context of anti-tumor
immunity, little is known about LAG-3+ NK cells in healthy
donors (22, 23). We observed expression of LAG-3 on NK cells
in only three out of 18 donors (5.23, 6.95, and 11.7% expression,
respectively). One possible explanation for the presence of
exhausted NK-cell subsets within otherwise healthy individuals
may be an ongoing, asymptomatic viral infection or virus
reactivation. Likewise, the function of TLT-2 on NK cells has
not been investigated yet. TLT-2 is a TREM family receptor
expressed on granulocytes, monocytes, and B cells. The receptor
is involved in multiple immunological processes such as
neutrophil chemotaxis, regulation of terminal neutrophil
effector functions, and phagocytosis of apoptotic cells by
macrophages (24).
The highest inter-individual variability in expression was
observed for the surface molecules CD2, CD58 (LFA-3), CD161,
and CD205. Several of these are known to participate in recognition
of aberrant cells or mediate other NK-cell functions. For example,
CD58 and CD2 are a pair of reciprocal adhesion molecules
mediating heterotypic and homotypic intercellular recognition.
CD2 is well established as one of the major costimulatory NK-
cell receptors binding to CD58 expressed on target cells (25).
Additionally, CD2 and CD58 also contribute to NK-cell cross-
talk by providing costimulatory signals among NK cells themselves
which regulate the development of NK-cell effector functions (26).
However, little is known about the functional impact of differential
expression of CD58 and CD2 between individuals. Notably, we
observed no correlation for expression of CD2 and CD58 within
individual donors. CD161 is an inhibitory NK-cell receptor that
binds to its ligand LLT1 on—predominantly activated—B cells and
DCs (27). Expression of CD161 decreases with aging as well as
following HCMV infection which may explain some of the inter-
individual variability we observed (28). As all blood samples used in
our study were donated anonymously, i.e. without information on
age, gender, or CMV-serostatus, we were unable to investigate the
influence of these factors on the observed differences in surface
expression. CD205 is an antigen uptake receptor commonly
used for phenotypic identification of DCs and is associated with
induction of immune tolerance in DCs (29). NK cells express
CD205 on their surface but its functional impact for NK cells
remains uncertain (30).
Altogether, the observed inter-individual differences of these
particular receptors may lead to differential NK-cell functionality
and thus potentially contribute to a diverging ability to control
viral infections or malignancies.
To address the differences in the receptor repertoire of NK
cells within each individual and between major NK-cell subsets,
we characterized the phenotypes of CD56bright and CD56dim
NK cells. Seventy molecules were differentially expressed by theseDecember 2020 | Volume 11 | Article 568927
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Moreover, unsupervised hierarchical clustering confirmed major
phenotypic differences between CD56bright and CD56dim NK
cells. This resembles recent transcriptome data on peripheral
blood NK cells that demonstrated clustering of CD56bright and
CD56dim NK cells as well (31, 32). Interestingly, unsupervised
hierarchical clustering did not result in the discrimination of NK
cells into functionally divergent educated and uneducated NK-
cell subsets. These observations are in line with recent
investigations into the transcriptional profiles of educated and
uneducated NK cells (33). A possible explanation for the lack of
clear phenotypic and transcriptional differences between
educated and uneducated NK cells is that NK-cell education
does not alter receptor repertoires to a currently detectable
degree and that changes induced by education primarily affect
intracellular signaling (33).
Among the known functional differences between CD56bright
and CD56dim NK cells is their response to different types of input
stimuli:CD56dimNKcells aremoreprone to respondtocell surface
ligands encountered in cell-cell interactions while CD56bright NK
cells rather respond to soluble ligands such as cytokines and
chemokines produced by other immune cells (4). Our results
confirm the predominant expression of several surface molecules
involved in mediating cell-cell interactions on CD56dim NK cells
(e.g. CD31, ADAM8, CD226, GPR56, CD53, CD81, and CD151).
Furthermore, we discovered differential expression between
CD56bright and CD56dim NK cells for CD58, CD147, HLA-E,
and CD82 which were, to our best of knowledge, not reported
before. CD58 (LFA-3) and CD147 both mediate intercellular
recognition and were predominantly expressed on CD56dim NK
cells that primarily recognize ligands bound to cell-surfaces (26,
34). Notably, CD58 expression was not only different between
the two major NK-cell subsets but also associated with great
variability between different individuals as discussed above.
HLA-E is a non-classical HLA class I molecule that mediates
effector responses of NK and T cells by presentation of leader
peptides derived from classical HLA class I as well as pathogen-
or stress-associated peptides. Engagement of HLA-E with
activating receptor CD94/NKG2C may trigger NK-cell effector
functions while engagement with CD94/NKG2A delivers
inhibitory signals to NK cells (35). Additionally, signaling via
CD94/NKG2A is one of the twomajor routes to facilitate NK-cell
education i.e. to shape functional capacities of NK cells via
certain self-reactive inhibitory receptors (36). Inter-individual
differences in expression depending on certain genetic
polymorphisms as well as altered expression in several disease
settings—e.g. viral infections or malignant tumors—are well
established (35, 37, 38). In contrast, to our best knowledge no
data on differential expression by NK-cell subsets has been
published. CD82 is a tetraspanin associated with inhibitory
signaling and limiting cytotoxicity in NK cells. Generally,
tetraspanins organize surface proteins into a highly organized
network that is composed of different molecules and participates
in various functions in each cell type (39, 40). Little is known
though about the components and functions of the network in
NK cells—and even less on differences between CD56bright andFrontiers in Immunology | www.frontiersin.org 11CD56dim NK cells. CD82 was primarily expressed on
CD56bright NK cells. Another tetraspanin, CD81, is involved
in NK-cell recruitment towards chemokines and cytokines (41).
If CD82 fulfilled a similar role as CD81 in NK cells, predominant
expression of CD82 might contribute to the ability of
CD56bright NK cells to sensitively respond to cytokines and
chemokines. Analogous functional properties for CD81 and
CD82 in NK cells were demonstrated before as well as
involvement of CD82 in chemokine-induced migration of DCs
(39, 42).
Only 34 of the 104 surface molecules expressed on at least one
of the major NK-cell subsets were not differentially expressed
between CD56bright and CD56dim NK cells. Those receptors
with equal expression on both subsets included activating NCR
Nkp46, costimulatory 2B4 and adhesion molecules CD18 and
CD11a (the two subunits of LFA-1) which were expressed on
virtually all NK cells. Equipment of NK cells with these receptors
may ensure a minimum level of activation potential regardless of
NK-cell subset and thus be a prerequisite for all NK cells to fulfill
their designated immune functions.
Altogether, we confirmed established differences in the receptor
repertoire of CD56bright and CD56dim NK cells and identified
additional surface molecules that contribute to the vast phenotypic
differences of the major NK-cell subsets. Intriguingly, all of those
were already implied in various immune functions for other cell
types that allowed us to hypothesize upon possible functional
implications for CD56bright and CD56dim NK cells.
Our flow cytometry-based phenotypic analysis provided new
insights into the vast diversity of NK-cell phenotypes and shed
light onto inter-individual differences in receptor profiles utilized
by NK cells. Limitations of our approach include a rather high
amount of NK cells required for the analysis of NK-cell sub-
populations and potential alterations of certain receptors during
sample processing (i.e. density centrifugation, overnight culture,
use of cytokines). Nevertheless, our findings contribute to a
better understanding of the phenotypic differences underlying
differential functionality of NK cells on an inter-individual level,
which determine e.g. different disease susceptibilities or
differential abilities to control malignancies. Additionally, we
further characterized the two major NK-cell subsets to better
comprehend how the different functional roles of CD56bright
and CD56dim NK cells are enabled by the variegated equipment
with surface receptors. As our approach for phenotypic
characterization is based on flow cytometry it may be used in
conjunction with additional techniques to investigate other
relevant NK-cell functions and thus be adapted to various
fields of interest. Especially given the current developments in
tumor immunotherapy, further insights into NK-cell-mediated
recognition of aberrant cells may help in harnessing NK-cell
properties for therapeutic strategies and clinical applications.DATA AVAILABILITY STATEMENT
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